Rbf Capital, LLC Sqz Biotechnologies CO Transaction History

Rbf Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$0.53 - $0.87 $28,225 - $46,332	-53,256 Reduced 41.63%	74,674 $41,000
Q4 2022 Feb 14, 2023	SELL	$0.67 - $2.85 $1,386 - $5,899	-2,070 Reduced 1.59%	127,930 $94,000
Q3 2022 Nov 14, 2022	BUY	$2.16 - $3.48 $108,000 - $174,000	50,000 Added 62.5%	130,000 $296,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $5.0 $221,600 - $400,000	80,000 New	80,000 $254,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.